Logo Logo Logo
  • Home
  • About Us
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
Logo Logo Logo Logo Logo Logo
  • Home
  • About Us
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
 

IECA Tag

28 Ene [133] Tratamiento de la hipertensión esencial: después de las tiazidas, ¿un IECA o ARA II?

Posted at 15:32h in Therapeutics Letter-ES 0 Comments
Share

En el número 7 de Therapeutics Letter publicado en 1995, se resumió la evidencia sobre tratamiento farmacológico óptimo para la hipertensión esencial, concluyendo que las tiazidas deberían ser los medicamentos de elección.1 Con la publicación...

Read More

accidente cerebrovascular agentes antibacterianos Anticoncepción postcoital antidepresivos ARA II Atomoxetina cannabis cascada de prescripción cistitis aguda clindamicina control glucémico costos de medicamentos covid-19 deprescribiendo desprescripción dolor dolor crónico dolor neuropático efectos adversos efectos secundarios y reacciones adversas relacionados con medicamentos factores de riesgo gabapentina IBP indacaterol infecciones dentales inhibición de la ovulación Inhibidores de la Bomba de Protones inhibidores de la enzima convertidora de la angiotensina LABA morfina Nirmatrelvir no opiáceos opioides oxicodona Paxlovid polimedicación pregabalina revisión sistemática Ritonavir seguridad seguridad del paciente seguridad de medicamentos sobrediagnóstico tramadol Trastorno por Déficit de Atención con Hiperactividad

Therapeutics Initiative logo

Our mission is to provide physicians, nurse practitioners, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. More about us

The Therapeutics Initiative is part of the Department of Anesthesiology, Pharmacology & Therapeutics at UBC's Faculty of Medicine.

Donate

 

Contact

Therapeutics Initiative
Dept of Anesthesiology, Pharmacology & Therapeutics
Faculty of Medicine
University of British Columbia

300 - 2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3

210 - 1110 Government Street
Victoria, BC, Canada V8W 1Y2

Office: +1 604-822-0700
Send us a message

 

Subscribe for Updates

Want to stay abreast of new therapeutics information? Then subscribe to receive email notices of upcoming Therapeutics Letters, educational events, and other announcements. We promise not to spam you and you won’t hear from us more than a few times a month.

Subscribe

Located on the traditional, ancestral and unceded territory of the hən̓q̓əmin̓əm̓ speaking peoples, including the xʷməθkwəy̓əm (Musqueam), the Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh), and the Skwxwú7mesh (Squamish) Nations, and on the lək̓ʷəŋən (Lekwungen) territory of the Songhees, Esquimalt and W̱SÁNEĆ peoples.

 
© Copyright 1994 - 2022 Therapeutics Initiative | Terms & Policies